Skip to content
OpenCapital
Get started

EyePoint, Inc. EYPT Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

ALN
Alnylam PharmaceuticalsALNY
$15.71M-65.9%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation?
EyePoint, Inc. (EYPT) reported cash provided by (used in) financing activity, including discontinued operation of -$2.61M in Q1 2026.
How has EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation decreased by 106.0% year-over-year, from $43.41M to -$2.61M.
What is the long-term trend for EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2022 to 2025), EyePoint, Inc. 's cash provided by (used in) financing activity, including discontinued operation has grown at a 531.4% compound annual growth rate (CAGR), from -$690K to $173.65M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.